Les Zuleski
Analyst, Truist
Replay available
Biote Corp. (NASDAQ: BTMD) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.

Analyst, Truist
Chief Executive Officer
Chief Financial Officer
Analyst, Jefferies
Analyst, Roth Capital Partners
Analyst, B. Reilly
Watch the replay and follow the connected company analysis, news, and investor updates for Biote Corp..
WEBVTT 00:00:00.031 -- 00:00:05.557 Hello and welcome to the BIOTE first quarter 2025 earnings conference call. 00:00:05.557 -- 00:00:08.439 All participants will be in listen-only mode. 00:00:08.439 -- 00:00:12.143 Should you need assistance, please signal a conference specialist by pressing the star 00:00:12.143 -- 00:00:17.348 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:17.348 -- 00:00:22.353 questions. To ask a question, you may press star, then one. 00:00:22.353 -- 00:00:24.536 Please note, this event is being recorded. 00:00:24.536 -- 00:00:29.617 I would now like to turn the conference over to Simon Seroviecki, Please go 00:00:29.617 -- 00:00:31.617 ahead. 00:00:32.800 -- 00:00:37.045 Thank you for joining us today. This afternoon, Dante published financial results for 00:00:37.045 -- 00:00:40.486 the first quarter ended March 31st, 2025. 00:00:40.569 -- 00:00:45.014 This news release is available in the investor relations section of the company's website. 00:00:45.014 -- 00:00:49.338 Hosting today's call are Brett Christensen, Chief Executive Officer, Bob Peterson, Chief 00:00:49.338 -- 00:00:53.102 Financial Officer, and Mark Beer, Executive Chairman. 00:00:53.102 -- 00:00:55.565 Before we get started, I would like to remind everyone that management will make statements 00:00:55.565 -- 00:00:59.667 during this call that include forward-looking statements regarding, among other things, 00:00:59.667 -- 00:01:04.954 the company's financial results, future performance growth opportunities, business outlook, 00:01:04.954 -- 00:01:10.742 strategies, goals, research and development, manufacturing and commercialization activities, 00:01:10.742 -- 00:01:15.809 competitive position, regulatory process operations, benefit...